News

Analysts Anticipate PVH Corp’s Earnings Drop This Quarter

Analysts Anticipate PVH Corp’s Earnings Drop This Quarter

Overview of PVH Corp's Upcoming Earnings Report

PVH Corp. (NYSE: PVH) is set to announce its earnings report for the third quarter shortly after market close. The anticipation around these earnings figures is palpable, particularly considering the company's ongoing adjustments and industry positioning.

Analysts' Predictions for Earnings

Market analysts are currently projecting that PVH will reveal earnings per share of approximately $2.54 for the quarter. This marks a decline from the $3.03 per share reported during the same period last year. However, there is a slight uptick expected in revenue, with projections pointing towards $2.28 billion compared to $2.26 billion from a year earlier. These insights are based on recent analytics and expectations of market movements.

Company Leadership Changes

In a significant development, PVH recently announced that Chief Financial Officer Zac Coughlin will be leaving the company to explore new opportunities outside the retail and apparel industry. This change in leadership comes at a crucial time as the company prepares for its earnings announcement.

Market Reaction Following Leadership Changes

In line with these changes, shares of PVH experienced a minor dip, decreasing 0.6% to $84.74 during the latest trading session. Investor sentiment has been closely aligned with the company's evolving leadership dynamic, which adds another layer of complexity to the upcoming financial report.

Most Accurate Analysts' Select Ratings

Insights from analysts show diverse perspectives on PVH's stock performance:

Ratings from Telsey Advisory Group

Telsey Advisory Group's Dana Telsey retained an Outperform rating for PVH, maintaining a price target of $95 as of Nov. 19, 2025. Telsey has shown a consistent accuracy rate of 62% in her forecasts.

BTIG's Buy Initiation

BTIG analyst Robert Drbul recently initiated coverage on PVH with a Buy rating and set a price target of $100, reflecting his optimistic view on the company's prospects with an accuracy of 64%.

Goldman Sachs Outlook

Goldman Sachs analyst Brooke Roach also kept a Buy rating, increasing the price target from $81 to $91 on Aug. 28, 2025, boasting an accuracy rate of 60%.

Wells Fargo's Strategy

Wells Fargo's Ike Boruchow maintained an Equal-Weight rating, lifting the price target from $80 to $88 on the same date, reflecting a strong accuracy rate of 72%.

UBS's Performance Forecast

UBS's analyst Jay Sole opted for a Buy rating, raising the price target from $146 to $148 on Aug. 28, 2025, with an accuracy of 68%. This shows strong confidence in the company's long-term viability.

The Road Ahead for PVH

As analysts weigh in on the company's outlook against the backdrop of recent leadership changes, investors are encouraged to remain informed about PVH's trajectory. The dual focus on quarterly performance and strategic leadership decisions adds a layer of importance to the impending report. Enthusiasts looking to further understand market dynamics around PVH can explore current analyst ratings and insights, which can be helpful for making informed investment decisions.

Frequently Asked Questions

What are analysts predicting for PVH's earnings this quarter?

Analysts anticipate PVH's earnings to be around $2.54 per share, down from $3.03 last year.

Has there been a change in leadership at PVH?

Yes, PVH's CFO Zac Coughlin announced his departure to pursue new opportunities outside the industry.

How are PVH's shares performing ahead of the earnings call?

PVH shares fell by 0.6% recently, closing at $84.74.

What are the price targets set by analysts for PVH?

Analysts have varying price targets, with the highest being $148 from UBS, reflecting strong confidence in the company's potential.

Where can I find more information about PVH's analyst ratings?

Investors can access detailed analyst ratings and recommendations on stock information platforms focusing on PVH.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Aging at Home: The Real Costs and Obstacles Ahead

Updated Category News Views 9

Facing the Realities of Aging In Place Alright, let's talk straight. Everyone dreams of staying home in their twilight years, kicking back in their favorite chair with family nearby. But the harsh truth? That comfort comes with a price tag. According to Northwestern Mutual's 2026 Planning & Progress Study, up to 83% of Boomers+ and most other generations fancy the idea of...

Continue Reading
OMLYCLO Shakes Up U.S. Biologic Market as Key Player

Updated Category News Views 13

Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...

Continue Reading
Hiromi Asai's Akatsuki Shines at Paris Fashion Week

Updated Category News Views 9

An Ode to Tradition Amid Modern Menswear From the bustling avenues of New York to the storied streets of Paris, Hiromi Asai is showcasing something that strikes a chord deep in the fashion industry's soul. Her Spring/Summer 2027 collection, "Akatsuki — Before the Dawn," takes its rare blend of age-old Japanese textile craftsmanship across the pond to the City of Light....

Continue Reading
China Automotive Systems Hits Milestone with ASPICE 4.0 CL2

Updated Category News Views 13

An Automotive Feat in R&D Now here's a story that should make waves across the automotive sector. China Automotive Systems, Inc. (NASDAQ: CAAS), a titan of power steering development in China, has nailed it by meeting the ASPICE 4.0 Capability Level 2. That's a big one, folks. Verified by a partnership between a European automaker and UL, this achievement is no fluke....

Continue Reading
Metropolitan Dermatology's Strategic Expansion into Barnegat

Updated Category News Views 12

Diving into Barnegat's Dermatology Landscape Metropolitan Dermatology has taken a strategic step by opening a new location right in the heart of Barnegat, New Jersey. Talk about a win-win for the folks in Ocean County. This isn't just another clinic opening up shop; it's about bringing comprehensive medical and surgical dermatologic care straight to the people who need...

Continue Reading
Event Industry Power 50 Voting Surge Ahead of Close

Updated Category News Views 11

An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....

Continue Reading
GL1F Crypto: A Breakthrough in On-Chain AI for Crypto

Updated Category News Views 7

The Dawn of On-Chain Machine Learning In a world where crypto folks often tout decentralization like it’s the holy grail, GenesisL1 is throwing open the doors to a new kind of crypto playground with GL1F Crypto. A decentralized on-chain AI studio? Sounds like sci-fi, but here we are—hands on the precipice of democratized machine learning in your browser. A Lab in...

Continue Reading
Travelers Turn to Direct Booking Amid Cost Surge

Updated Category News Views 17

Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...

Continue Reading
Christmas Injury Lawyers Unveils SC Knowledge Center

Updated Category News Views 6

In the world of legal labyrinths, sometimes you just need a guiding light, especially following a car accident. That's where the freshly launched South Carolina Car Accident Law Knowledge Center steps in. It’s no magic wand, but Christmas Injury Lawyers are certainly trying to cut the chaos. This online hub covers more ground than a small library, boasting 40 guides...

Continue Reading
Hilarity and Hassles in NYC Co-op Life Exposed in New Book

Updated Category News Views 14

Co-op Living: Not All It's Cracked Up to Be Let me tell you something, buying a co-op in New York City isn't just signing on the dotted line and moving in. Nope, it's a whole damn production. Jeff Namian's book, Thin Walls/Thick Ears, lays it all out with a mix of humor and hard truths, painting a stark picture of NYC co-op living. He's not just telling his own story of...

Continue Reading

Top 5 Most Recently Viewed Articles

House Republicans Push for Transparency on Ukraine Strategy Report

Updated Category News Views 52

The U.S. House of Representatives is buzzing with GOP leaders demanding clarity from the Biden administration regarding its Ukraine strategy. This call to action is escalating ahead of Ukrainian President Volodymyr Zelenskiy's anticipated visit to Capitol Hill for discussions that could influence U.S. support. Congress’ Financial Lifeline Let’s get one thing...

Continue Reading
GCM Grosvenor and Wilshire Indexes Collaborate on New Index

Updated Category News Views 115

GCM Grosvenor and Wilshire Indexes Introduce Private Market Index LONDON and CHICAGO — GCM Grosvenor (NASDAQ: GCMG), a renowned provider of alternative asset management solutions, has partnered with Wilshire Indexes, a leader in index design, to launch the FT Wilshire Private Markets Infrastructure Index. This innovative index aims to enhance investment opportunities by...

Continue Reading
Seven Verbs Introduces Tailored Software Solutions for Growth

Updated Category News Views 160

Affordable Software Development Packages for Startups Seven Verbs, an innovative player in custom software development, has launched its new Tailored Software Development Packages aimed at helping startups and medium-sized businesses thrive. These packages are tailored to offer affordable and high-quality software solutions, enabling organizations to quickly transform...

Continue Reading
Understanding Sabra Health Care REIT's Tax Information for 2024

Updated Category News Views 297

Understanding Distribution Tax Treatment for Sabra Health Care REIT In an important announcement, Sabra Health Care REIT, Inc. (NASDAQ: SBRA) has clarified the tax treatment for its distributions in 2024. This information is particularly relevant for shareholders as it provides insights into how these financial distributions are categorized for tax purposes. Overview of...

Continue Reading
Sam Altman Confronts Elon Musk Over OpenAI Controversy

Updated Category News Views 290

Sam Altman's Response to Elon Musk's Accusations The ongoing dispute between billionaire Elon Musk and Sam Altman has reached new heights as Musk accused OpenAI, led by Altman, of theft. This latest exchange adds fuel to their public rivalry, highlighting tensions in the tech industry. Altman Defends OpenAI's Transformation In response to Musk's accusations, Altman...

Continue Reading